The Repeat-In-Toxin Family Member TosA Mediates Adherence of Uropathogenic Escherichia coli and Survival during Bacteremia

ABSTRACT Uropathogenic Escherichia coli (UPEC) is responsible for the majority of uncomplicated urinary tract infections (UTI) and represents the most common bacterial infection in adults. UPEC utilizes a wide range of virulence factors to colonize the host, including the novel repeat-in-toxin (RTX) protein TosA, which is specifically expressed in the host urinary tract and contributes significantly to the virulence and survival of UPEC. tosA, found in strains within the B2 phylogenetic subgroup of E. coli, serves as a marker for strains that also contain a large number of well-characterized UPEC virulence factors. The presence of tosA in an E. coli isolate predicts successful colonization of the murine model of ascending UTI, regardless of the source of the isolate. Here, a detailed analysis of the function of tosA revealed that this gene is transcriptionally linked to genes encoding a conserved type 1 secretion system similar to other RTX family members. TosA localized to the cell surface and was found to mediate (i) adherence to host cells derived from the upper urinary tract and (ii) survival in disseminated infections and (iii) to enhance lethality during sepsis (as assessed in two different animal models of infection). An experimental vaccine, using purified TosA, protected vaccinated animals against urosepsis. From this work, it was concluded that TosA belongs to a novel group of RTX proteins that mediate adherence and host damage during UTI and urosepsis and could be a novel target for the development of therapeutics to treat ascending UTIs.

[1]  Andrew P. Hodges,et al.  Presence of Putative Repeat-in-Toxin Gene tosA in Escherichia coli Predicts Successful Colonization of the Urinary Tract , 2011, mBio.

[2]  C. Alteri,et al.  Identification of In Vivo-Induced Antigens Including an RTX Family Exoprotein Required for Uropathogenic Escherichia coli Virulence , 2011, Infection and Immunity.

[3]  Hee Kyung Choi,et al.  Risk factors of all-cause in-hospital mortality among Korean elderly bacteremic urinary tract infection (UTI) patients. , 2011, Archives of gerontology and geriatrics.

[4]  H. Mobley,et al.  Dissemination and Systemic Colonization of Uropathogenic Escherichia coli in a Murine Model of Bacteremia , 2010, mBio.

[5]  I. Linhartova,et al.  RTX proteins: a highly diverse family secreted by a common mechanism , 2010, FEMS microbiology reviews.

[6]  D. Rasko,et al.  Escherichia coli Global Gene Expression in Urine from Women with Urinary Tract Infection , 2010, PLoS pathogens.

[7]  U. W. Hultdin,et al.  Structure of FocB – a member of a family of transcription factors regulating fimbrial adhesin expression in uropathogenic Escherichia coli , 2010, The FEBS journal.

[8]  L. Baddour,et al.  Bacteremia complicating gram-negative urinary tract infections: a population-based study. , 2010, The Journal of infection.

[9]  T. J. Wiles,et al.  Use of Zebrafish to Probe the Divergent Virulence Potentials and Toxin Requirements of Extraintestinal Pathogenic Escherichia coli , 2009, PLoS pathogens.

[10]  H. Mobley,et al.  Genomic Islands of Uropathogenic Escherichia coli Contribute to Virulence , 2009, Journal of bacteriology.

[11]  R. Conran,et al.  Hemolysin of Uropathogenic Escherichia coli Evokes Extensive Shedding of the Uroepithelium and Hemorrhage in Bladder Tissue within the First 24 Hours after Intraurethral Inoculation of Mice , 2008, Infection and Immunity.

[12]  J. Hacker,et al.  Regulatory Interactions among Adhesin Gene Systems of Uropathogenic Escherichia coli , 2007, Infection and Immunity.

[13]  Karla J. F. Satchell.  MARTX, Multifunctional Autoprocessing Repeats-in-Toxin Toxins , 2007, Infection and Immunity.

[14]  D. Rasko,et al.  Defining Genomic Islands and Uropathogen-Specific Genes in Uropathogenic Escherichia coli , 2007, Journal of bacteriology.

[15]  R. Welch,et al.  In Vivo Gene Expression Analysis Identifies Genes Required for Enhanced Colonization of the Mouse Urinary Tract by Uropathogenic Escherichia coli Strain CFT073 dsdA , 2006, Infection and Immunity.

[16]  C. Buchrieser,et al.  How to become a uropathogen: Comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains , 2006, Proceedings of the National Academy of Sciences.

[17]  Jonathan R Edwards,et al.  Overview of nosocomial infections caused by gram-negative bacilli. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  S. Beatson,et al.  Prevalence of Pathogenicity Island IICFT073 Genes among Extraintestinal Clinical Isolates of Escherichia coli , 2005, Journal of Clinical Microbiology.

[19]  F. Blattner,et al.  Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Hacker,et al.  Efficient expression of the α-haemolysin determinant in the uropathogenic Escherichia coli strain 536 requires the leuX-encoded tRNA5Leu , 2002, Molecular Genetics and Genomics.

[21]  J. Hacker,et al.  Efficient expression of the alpha-haemolysin determinant in the uropathogenic Escherichia coli strain 536 requires the leuX-encoded tRNA(5)(Leu). , 2002, Molecular genetics and genomics : MGG.

[22]  B. Uhlin,et al.  PapB paralogues and their effect on the phase variation of type 1 fimbriae in Escherichia coli , 2001, Molecular microbiology.

[23]  I. Beacham,et al.  The aprX-lipA operon of Pseudomonas fluorescens B52: a molecular analysis of metalloprotease and lipase production. , 2001, Microbiology.

[24]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  B. Uhlin,et al.  Regulatory cross‐talk between adhesin operons in Escherichia coli: inhibition of type 1 fimbriae expression by the PapB protein , 2000, The EMBO journal.

[26]  A. Juárez,et al.  Interaction of the nucleoid-associated proteins Hha and H-NS to modulate expression of the hemolysin operon in Escherichia coli. , 2000, Advances in experimental medicine and biology.

[27]  T J Beveridge,et al.  Bacterial S-layers. , 1999, Trends in microbiology.

[28]  B. Uhlin,et al.  Oligomeric interaction of the PapB transcriptional regulator with the upstream activating region of pili adhesin gene promoters in Escherichia coli , 1998, Molecular microbiology.

[29]  T. Kato,et al.  Role for the S-layer of Campylobacter rectus ATCC33238 in complement mediated killing and phagocytic killing by leukocytes from guinea pig and human peripheral blood. , 2008, Oral diseases.

[30]  M. Castro,et al.  Neutrophil phagocytosis in AIDS patients with azole resistant candidiasis. , 1997, Oral diseases.

[31]  B. Brahamsha.  An abundant cell-surface polypeptide is required for swimming by the nonflagellated marine cyanobacterium Synechococcus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Soscia,et al.  The Pseudomonas fluorescens lipase has a C‐terminal secretion signal and is secreted by a three‐component bacterial ABC‐exporter system , 1994, Molecular microbiology.

[33]  M. Kerr,et al.  The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis. , 1993, Journal of medical microbiology.

[34]  A. Siitonen,et al.  Characteristics of Escherichia coli in acute community-acquired cystitis of adult women. , 1993, Scandinavian journal of infectious diseases.

[35]  N. Nishino,et al.  Pseudomonas aeruginosa alkaline proteinase might share a biological function with plasmin. , 1991, Biochimica et biophysica acta.

[36]  R. Welch.  Pore‐forming cytolysins of Gram‐negative bacteria , 1991, Molecular microbiology.

[37]  I. Phillips,et al.  Bacteremia due to Escherichia coli: a study of 861 episodes. , 1990, Reviews of infectious diseases.

[38]  H. Mobley,et al.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains , 1990, Infection and immunity.

[39]  S. Sakurada,et al.  Comparative studies on the biology of Actinobacillus actinomycetemcomitans leukotoxin in primates. , 1987, Oral microbiology and immunology.

[40]  S. Normark,et al.  Transcriptional activation of a pap pilus virulence operon from uropathogenic Escherichia coli. , 1985, The EMBO journal.

[41]  J. Hacker,et al.  Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice , 1983, Infection and immunity.

[42]  R. Freter,et al.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin , 1983, Infection and immunity.

[43]  W. Anthony,et al.  A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. , 1983, Reviews of infectious diseases.

[44]  F. O'grady,et al.  Uropathogenic properties of Escherichia coli in recurrent urinary-tract infection. , 1980, Journal of medical microbiology.

[45]  L.,et al.  The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis , 2022 .